ArticleFrontiers in cell and developmental biology2021

The Synergistic Effects of SHR6390 Combined With Pyrotinib on HER2+/HR+ Breast Cancer.

Yukun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.